Beta-Alanine

Beta-Alanine

SCHEMBL27722682

NC(=O)N1CCCCC1.NCCC(=O)O

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MAPK1 P28482 1/20 0.42
DPP7 Q9UHL4 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.39
HTT P42858 1/20 0.39
ATM Q13315 1/20 0.39
ALDH1A1 P00352 2/20 0.38
KMT2A Q03164 2/20 0.38
GABRR3 A8MPY1 1/20 0.38
GABRP O00591 1/20 0.38
GABRD O14764 1/20 0.38
HDAC3 O15379 1/20 0.38
GABBR2 O75899 1/20 0.38
LMNA P02545 1/20 0.38
THRB P10828 1/20 0.38
GABRA1 P14867 1/20 0.38
TSHR P16473 1/20 0.38
GABRB1 P18505 1/20 0.38
GABRG2 P18507 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Beta-Alanine SCHEMBL9092097 0.98 ATM (0.40) CYP1A2SMN1; SMN2MAPK1DPP7L3MBTL1
Succinic Acid SCHEMBL5411814 0.90 SMN1; SMN2 (0.47) CYP1A2SMN1; SMN2MAPK1DPP7L3MBTL1
Succinic Acid SCHEMBL5403541 0.87 ATM (0.44) CYP1A2SMN1; SMN2MAPK1DPP7L3MBTL1
Glutarate SCHEMBL5406232 0.86 CYP1A2 (0.53) CYP1A2SMN1; SMN2MAPK1L3MBTL1HTT
Glycine SCHEMBL8830859 0.85 GLRA1 (0.46) CYP1A2SMN1; SMN2MAPK1DPP7L3MBTL1
Glycine SCHEMBL8830879 0.83 GLRA1 (0.48) CYP1A2SMN1; SMN2MAPK1DPP7L3MBTL1
Hydrochloric Acid SCHEMBL8356810 0.82 LMNA (0.59) CYP1A2SMN1; SMN2MAPK1L3MBTL1ATM
SCHEMBL4055560 0.81 CYP1A2 (0.48) CYP1A2SMN1; SMN2MAPK1L3MBTL1HTT
SCHEMBL23963672 0.80 ALDH1A1 (0.55) DPP7L3MBTL1HTTATMALDH1A1
SCHEMBL1363949 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103130709-B 3-aminopropionic acid piperidine amide compound with HIV activity, synthetic method and application 常州亚邦制药有限公司 2017-04-12 CN disclosed
CN-103130709-B 3-aminopropionic acid piperidine amide compound with HIV activity, synthetic method and application 常州亚邦制药有限公司 2017-04-12 CN disclosed
CN-102319184-B Parakeratosis inhibitor, pore-shrinking agent and external composition for skin SHISEIDO CO LTD 2015-03-25 CN disclosed
CN-103130709-A 3-aminopropionic acid piperidine amide compound with HIV activity, synthetic method and application CHANGZHOU YABANG PHARMACEUTICAL CO LTD 2013-06-05 CN disclosed
CN-103130709-A 3-aminopropionic acid piperidine amide compound with HIV activity, synthetic method and application CHANGZHOU YABANG PHARMACEUTICAL CO LTD 2013-06-05 CN disclosed
CN-102319184-A Parakeratosis inhibitor, pore contracting agent and composition for external application SHISEIDO CO LTD 2012-01-18 CN disclosed
CN-101175470-B Parakeratosis inhibitor, pore-shrinking agent and external composition for skin SHISEIDO CO LTD 2011-09-14 CN disclosed
CN-101267803-B Wrinkle-improving agent SHISEIDO CO LTD 2011-06-08 CN disclosed
CN-101267803-A Wrinkle-improving agent SHISEIDO CO LTD (JP) 2008-09-17 CN disclosed
CN-101175470-A Parakeratosis inhibitor, pore-shrinking agent and external composition for skin SHISEIDO CO LTD (JP) 2008-05-07 CN disclosed